APPROVED USE

KOĀTE (Antihemophilic Factor (Human)) is a medicine used for the control and prevention of bleeding episodes or in order to perform emergency and elective surgery in patients with hemophilia A (hereditary Factor VIII deficiency). KOĀTE is not approved for the treatment of von Willebrand disease.

IMPORTANT SAFETY INFORMATION

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/MedWatch, or call 1-800-FDA-1088.

Please click here for the Full Prescribing Information.

 

Koāte is a registered trademark of Kedrion Biopharma Inc.
All other trademarks are the property of their respective owners.
©2019 Kedrion Biopharma Inc. All rights reserved. April 2019 KT-0608-01-2018

Back to top